Sort
53,477 grants matching “addiction”
4/24 Healthy Brain and Child Development National Consortium
$1,128,549Julie A Kable · Emory University · U01 · FY2022 · DA
Emory-GSK-NIMH Collaborative Mood Disorders Initiative
$1,128,476Charles B Nemeroff · Emory University · U19 · FY2006 · MH
Presynaptic Mechanisms of Neural Plasticity
$1,128,057Robert H Edwards · University Of California, San Francisco · P01 · FY2012 · DA
Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19
$1,128,033David H Gustafson · University Of Wisconsin-Madison · R01 · FY2021 · AA
Precision editing of neural circuits using engineered electrical synapses
$1,127,000Kafui Dzirasa · Duke University · DP1 · FY2022 · MH
Precision editing of neural circuits using engineered electrical synapses
$1,127,000Kafui Dzirasa · Duke University · DP1 · FY2024 · MH
Precision editing of neural circuits using engineered electrical synapses
$1,127,000Kafui Dzirasa · Duke University · DP1 · FY2023 · MH
Precision editing of neural circuits using engineered electrical synapses
$1,127,000Kafui Dzirasa · Duke University · DP1 · FY2025 · MH
Does Dopamine Mediate Effects of Stress on Inhibitory Control and Smoking Lapse?
$1,126,986Evan D Morris · Yale University · R01 · FY2022 · DA
Impact of Marijuana Legalization: Comparison of Two Longitudinal Twin Cohorts
$1,125,962Christian J Hopfer · University Of Colorado Denver · R01 · FY2017 · DA
MOLECULAR NEUROBIOLOGY OF DRUG ADDICTION
$1,125,499University Of Texas Sw Med Ctr/Dallas · P01 · FY2002 · DA
Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19
$1,125,359David H Gustafson · University Of Wisconsin-Madison · R01 · FY2022 · AA
Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19
$1,125,162David H Gustafson · University Of Wisconsin-Madison · R01 · FY2023 · AA
Administrative Core
$1,125,038David Edward Thompson · Kansas State University · P20 · FY2025 · GM
Clinical Trials Network: Southwest Node
$1,124,902Michael Parks Bogenschutz · University Of New Mexico · U10 · FY2010 · DA
NEW MODALITIES FOR TREATMENT OF PAIN AND DRUG ABUSE
$1,124,728Victor J Hruby · University Of Arizona · P01 · FY2013 · DA
Spinal Manipulation and Patient Self-Management to Prevent Back Pain Chronicity
$1,124,469Gert Bronfort · University Of Minnesota · UH3 · FY2022 · AT
Development of a Novel Chemokine Receptor Antagonist as a Treatment for Opioid Use Disorder
$1,123,774Michael R Ruff · Creative Bio-Peptides, Inc. · R44 · FY2022 · DA
Development and Implementation of a Culturally Centered Opioid Prevention Intervention for American Indian/Alaska Native Young Adults in California
$1,123,338Elizabeth J D'amico · Rand Corporation · UH3 · FY2021 · DA
Characterization of Molecular Pathways in Chronic Pain Conditions
$1,123,168Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIA · FY2024 · DE
Emory-GSK-NIMH Collaborative Mood Disorders Initiative
$1,122,582Clinton D Kilts · Emory University · U19 · FY2007 · MH
Alcohol Pharmacokinetics and Pharmacodynamics in Humans
$1,122,494Vijay Arjun Ramchandani · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA
Defining neurobiological links between substance use and mental illness
$1,122,369Amy Janes · National Institute On Drug Abuse · ZIA · FY2022 · DA
Pharmacology and toxicology of newly-emerging designer drugs of abuse
$1,122,362Michael Baumann · National Institute On Drug Abuse · ZIA · FY2019 · DA
Clinical Trials Network: Southwest Node
$1,122,294Michael Parks Bogenschutz · University Of New Mexico · U10 · FY2011 · DA